Editor: Asis Bala

Diabetes and Breast Cancer: An Analysis of Signaling Pathways

eBook: US $49 Special Offer (PDF + Printed Copy): US $84
Printed Copy: US $59
Library License: US $196
ISBN: 978-981-5256-03-1 (Print)
ISBN: 978-981-5256-02-4 (Online)
Year of Publication: 2024
DOI: 10.2174/97898152560241240101

Introduction

Diabetes and Breast Cancer: An Analysis of Signaling Pathways an in-depth monograph that explores the cross-talk between diabetes and breast cancer. The edited volume sheds light on the complex relationship between the two diseases by explaining the critical regulatory signaling in their progression.

Topics covered in the book include the genetic similarities between type 2 diabetes and breast cancer, signaling pathways for breast cancer cell invasion and migration (including fat cadherin, Wnt signaling and IGF signaling).and research on associated conditions such as neuropathy, inflammation, hypoxia and obesity. A summary of natural

Scholars, academicians, and professionals in medicine and pharmaceutical research who want to gain a better understanding of the complex interplay between diabetes and breast cancer will learn about the underlying biochemical mechanisms, the pharmacological targets, and the pharmacogenomics and precision medicine approaches for the simultaneous management of both diseases

Key Features

  • - Gives a comprehensive overview of the cross-talk between diabetes and breast cancer
  • - Covers information on multiple signaling pathways and associated conditions
  • - Provides insights contributed by biomedical experts with detailed references

Readership

Research scholars, academicians, healthcare professionals (endocrinologists, oncologists, internal medicine specialists) and R&D professionals in pharmaceutical chemistry.

Preface

Research has shown that breast cancer patients with diabetes experience worse clinical outcomes compared to those without diabetes, indicating a possible link between diabetes and breast cancer cell progression and migration. The exact reasons for this association are still being studied, but it is believed that factors such as hyperglycemia and hyperinsulinemia in type 2 diabetes may play a role. To better understand this link between diabetes and breast cancer, it is important to thoroughly investigate the signaling pathways involved. By doing so, biomedical scientists may be able to develop more effective treatments that target these mechanisms. The main focus of this book is to provide a detailed analysis of the signaling cross-talk between diabetes and breast cancer, with the goal of facilitating future drug development and improving patient outcomes. This book elucidates the critical signaling mechanisms and signaling Analysis to cross-talk between Diabetes and Breast Cancer. The key features include-

- Explains the role of critical regulatory signaling for Breast cancer progression during diabetes and obesity-associated conditions.

- Covers and explores the Genetic similarity between type 2 Diabetes and breast cancer.

- Systematically explains the signaling analysis to insulin for breast cancer cell invasion and migration and explores the possible pharmacological target for its concomitant management.

- Outline the Pharmacogenomics and Precision medicine approaches in relation to Diabetes and Breast Cancer.

This book is designed to provide valuable insights into the complex signaling mechanisms that link diabetes and breast cancer. This book is a useful resource for biomedical scientists in academia, the bio-pharmaceutical and biotechnological industries, as well as individual researchers and PhD scholars. By delving into the intricacies of this cross-talk, the book aims to facilitate the development of future drugs that can target these signaling pathways more effectively. Furthermore, as the first of its kind, this book will serve as a go-to reference for academics and students seeking a comprehensive understanding of this crucial field.

Asis Bala

Division of Life Sciences Institute of
Advanced Study in Science and Technology (IASST)
An Autonomous Institute under-
Department of Science & Technology (Govt. of India)
Vigyan Path, Guwahati-781035, Assam
India